INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
25 avr. 2024 09h00 HE
|
INmune Bio, Inc.
Boca Raton, Florida, April 25, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the...
Ntara to unveil 2024 US Manufacturers Digital Benchmarking Study at PIMpoint Chicago
24 avr. 2024 08h00 HE
|
Ntara
Ntara debuts its inaugural 2024 Manufacturers Digital Commerce Benchmarking Study during a keynote presentation at inriver PIMpoint in Chicago.
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
24 avr. 2024 07h00 HE
|
atai Life Sciences
The BPL-003 Phase 2a trial is an open-label study investigating BPL-003 as both monotherapy and adjunctive to SSRIs in patients with Treatment Resistant Depression.Initial results from the recently...
[Latest] Global Flavours and Fragrances Market Size/Share Worth USD 50.7 Billion by 2033 at a 4.82% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
23 avr. 2024 03h30 HE
|
Custom Market Insights
Austin, TX, USA, April 23, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Flavours and Fragrances Market Size, Trends and Insights By Type (Flavours,...
Pixalate Releases Q1 2024 Mobile Supply-Side Platform (SSP) Global Market Share Rankings for Apple App Store Apps: Google AdExchange No. 1 in North America (14%), Followed by Magnite (8%)
22 avr. 2024 15h05 HE
|
Pixalate Inc.
LONDON, April 22, 2024 (GLOBE NEWSWIRE) -- Pixalate, the market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and Mobile Advertising, today released the...
UPDATE - New Study Reveals Potential Treatment for Neurological Lyme Disease
19 avr. 2024 12h45 HE
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, recently announced publication of a laboratory study...
New Study Reveals Potential Treatment for Neurological Lyme Disease
18 avr. 2024 11h00 HE
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, recently announced publication of a laboratory study showing...
OPTIZMO™ Releases 2023 Email Opt-Out Infographic
18 avr. 2024 09h00 HE
|
OPTIZMO Technologies, LLC
The infographic presents unique insights and data from hundreds of millions of opt-out requests, focusing on timing, geographic location, and device usage.
Renewables and nascent low-carbon technologies most exposed to high interest rates
18 avr. 2024 06h25 HE
|
Wood Mackenzie
NEWS RELEASE Renewables and nascent low-carbon technologies most exposed to high interest rates Policymakers should...
atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
17 avr. 2024 07h00 HE
|
atai Life Sciences
BPL-003 is Beckley Psytech’s novel patent-protected benzoate salt formulation of 5-MeO-DMT that is administered intranasally.BPL-003 was shown to be safe and well-tolerated with a predictable...